Srikant (Sri) Ramaswami, executive VP/healthcare at rbb Communications, has joined Caris Life Sciences as VP-chief communications officer.
Prior to rbb, the 20-year pharma PR veteran worked at Merck, Pfizer and Johnson & Johnson.
At J&J, he spearheaded its pharmaceuticals effort in China and then served as VP/Asia-Pacific in the medical devices group.
Irving, TX-based CLS' molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps doctors/cancer patients make more precise and personalized treatment decisions.
CLS relies on The Ruth Group for media relations work.